SARS-CoV-2 Incidence Evolution in Itapúa, Paraguay, from February to August 2021
DOI:
https://doi.org/10.70833/rseisa16item256Keywords:
Covid-19, SARS-CoV-2, ItapúaAbstract
Approximately two years after the start of the Covid-19 pandemic, the number of confirmed cases in Paraguay by the end of August 2021 raises to 458,207 people, and the number of reported deaths to 15,653. This investigation was carried out in order to evaluate the evolution of the incidence of the SARS-CoV-2 virus in patient samples from the Molecular Biology laboratory of the Hospital Regional de Encarnación-Itapúa. The samples were taken during the months of February and August of 2021. A descriptive, prospective cross-sectional study was carried out where 22312 samples were analyzed. The identification of the virus was carried out mainly by the qRT-PCR technique Starting in May, the rapid test technique for antigen detection was introduced. The prevalence of positive cases for Covid-19 in patients residing in the department of Itapúa was 28% (6229), May being the month with the highest percentage of cases (23,24%, 1448). 55.5% of the cases (3460) represented the female group and the most affected age group was people between 21 and 40 years old was 51.2% (3191). The Ct value for the E gene had a mean of 24.75 ± 6.55. The most frequent comorbidities correspond to chronic heart disease, obesity, and diabetes. This study analyzed data from Itapúa that showed an increase in cases in the months between May and July. It was determined that there is a statistically significant relationship between suffering from some comorbidity and death caused by Covid-19.
Downloads
References
Chamorro, J. (2021). Planificación y Gestión Integral de La Pandemia COVID-19 En Paraguay . UNA Epidemiológicas, Económicas y Sociales.” CONACYT, 1–19.
Instituto Nacional de Salud y Centro Nacional de Epidemiología, Prevención y Control de Enfermedades-MINSA. 2021. Sala Situacional COVID-19 Perú. Retrieved (https://covid19.minsa.gob.pe/sala_situacional.asp).
Johns Hopkins University and Medicine. (2020). Coronavirus Resource Center. [Centro de investigación Coronavirus] Retrieved (https://coronavirus.jhu.edu/map.html).
Kidd, M., Richter, A., Best, A., Cumley, N., Mirza, J., Percival, B., Megram, O. et al. (2021). S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated with Significantly Higher Viral Loads in Samples Tested by ThermoFisher TaqPath RT-QPCR. [El linaje B1.1.7 del SARS-CoV-2 variante S se asocia con cargas virales significativamente más altas en muestras analizadas por ThermoFisher TaqPath RT-QPCR]. The Journal of Infectiuos Diseases 1–16.
Millán, J., Rodriguez, A., Camacho, G., & Mendoza, H. (2021). A New Emerging Zoonotic Virus of Concern: The 2019 Novel Coronavirus ( SARS CoV-2 ). [Un nuevo virus zoonótico emergente preocupante: el nuevo coronavirus de 2019 (SARS CoV-2)] Infectio 24(3):187–92.
Ministerio de Salud Pública y Bienestar Social. (2020). Reporte Paraguay MSPBS COVID19. Retrieved June 05, 2021
Organización Mundial de la Salud. (2021a). Coronavirus Disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. [Enfermedad por coronavirus (COVID-19) Actualización epidemiológica semanal y Actualización operativa semanal] Retrieved June 28, 2021 (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/).
Organización Mundial de la Salud. OMS. (2021b). Enfermedades No Transmisibles. Retrieved (https://www.who.int/es/news-room/fact-sheets/detail/noncommunicable-diseases).
OPS/OMS Paraguay. (2020). Respuesta de la OPS/OMS a la COVID-19 en Paraguay, enero a diciembre de 2020. 33.
OPS/OMS Paraguay. (2021). Reporte de Situación No. 57 OPS/OMS Paraguay 16. (39),2–5.
Plasencia, T., Aguilera, R. & Almaguer, L. (2020). Comorbilidades y Gravedad Clínica de La COVID-19: Revisión Sistemática y Meta-Análisis. Rev. Habanera Cienc. Méd 19.
Rearte, A., Baldani, A., Barcena, P., Domínguez, C., Laurora, M., Pesce, M., Rojas, M. et al. (2020). Características Epidemiológicas de Los Primeros 116 974 Casos de Covid-19 En Argentina, 2020. Revista Argentina de Salud Pública 12:1–9.
La Scola, B., Le Bideau, M., Andreani, J., Hoang, V., Grimaldier, C., Colson, Ph., Gautret, Ph., et al. (2020). Viral RNA Load as Determined by Cell Culture as a Management Tool for Discharge of SARS-CoV-2 Patients from Infectious Disease Wards. [Carga de ARN viral determinada por cultivo celular como herramienta de gestión para el alta de pacientes con SARS-CoV-2 de salas de enfermedades infecciosas] European Journal of Clinical Microbiology and Infectious Diseases 39(6):1059–61.
STANDARD Q COVID-19 Ag Test. (2020). Standart Q COVID-19 Ag.
Team, The Novel Coronavirus Pneumonia Emergency Response Epidemiology. (2021). The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. [Las características epidemiológicas de un brote de nuevas enfermedades por coronavirus de 2019 (COVID-19) — China, 2020] China CDC 2:3.
Downloads
Published
How to Cite
License
Copyright (c) 2022 Mónica María González , Diana Paola Dressler Sanabria , Liliana Noelia Talavera Stéfani
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution License CC-BY
You are free to:
Share — copy and redistribute the material in any medium or format.
Adapt — remix, transform, and build upon the material for any purpose, including commercially.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if any changes have been made. You may do so in any reasonable way, but not in any way that suggests that you or your use is endorsed by the Licensor.
